Dr. Ishita Aggarwal, MD

Dr. Aggarwal practices at California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD in San Francisco, California.

Dr. Aggarwal's NPI, 1518385699, was assigned on April 4, 2014. Dr. Aggarwal graduated from New York University School of Medicine in 2014. Dr. Aggarwal holds California license A138573.

Dr. Aggarwal's primary practice is California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD, at 2333 Buchanan St, San Francisco, CA 94115.

Dr. Aggarwal's primary practice is California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD in San Francisco, California. Dr. Aggarwal is also affiliated with California Pacific Medical Center Van Ness Campus. The medical group on file is Pacific Rheumatology Associates. Dmand AI also links Dr. Aggarwal to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aggarwal practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Aggarwal's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Aggarwal is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Aggarwal's licenses on file in 2 states: California and District of Columbia.

Dmand AI lists arteritis, arthritis, fluid in a joint, gout, joint arthropathy, joint pain, lupus and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Aggarwal treats.

CMS data shows 914 Medicare services from Dr. Aggarwal across 9 procedure codes in 2024, for 151 Medicare patients. Medicare paid $63,474 for them. Every service was in an office.

CMS counts 151 Medicare patients who saw Dr. Aggarwal in 2024. The largest group is 65 to 74, with 69 patients. 75% of them have arthritis, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Aggarwal's median patient age at 64, with 55% women.

In 2024, Dr. Aggarwal wrote 1,413 Medicare Part D claims for 173 patients. 79% of them were for generic drugs. CMS names the drug for 1,282 of them, across 23 drugs with 11 or more claims each, at $1,504,611 in total drug cost. In 2023, CMS named 1,142 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Aggarwal for performance year 2024, reported as part of a group. Dr. Aggarwal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Aggarwal as offering telehealth.

Dmand AI links 10 papers to Dr. Aggarwal, published from 2009 to 2023. 2018 was the busiest year, with 2. The most frequent topics are Immunosuppressive Agents, Caloric Restriction and Eating. Dr. Aggarwal has published most often in Am J Physiol Endocrinol Metab. Dr. Aggarwal's most frequent co-authors are Jinoos Yazdany, MD, Maria C. Dall'Era, MD and Marc Kopel Hellerstein, MD.

CMS Open Payments shows 483 general payments to Dr. Aggarwal from 30 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $2,205.

Dmand AI lists 1 award for Dr. Aggarwal, most recently Outstanding Research Award in 2019.

Dr. Aggarwal graduated from New York University School of Medicine in 2014.

Dr. Aggarwal is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.